Delivery Order SPE2DB22D2009-SPE2DB25FM0RJ
Award Date 8/4/25
Potential Completion Date 8/5/25
Potential Value $1.2K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Boostrix TDAP vaccine in syringe form (0.5mL) valued at $1,863.95 under a firm fixed price contract. The award was made on August 20, 2025, with an ultimate completion date of August 21, 2025, and represents a non-set-aside competitive award. Performance of this delivery order will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $140,147 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Boostrix TDAP vaccine in 0.5mL syringes. The order will be fulfilled at the company's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of September 4, 2025. This is a competitively awarded contract with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to meet federal vaccine...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Boostrix TDAP vaccine in 0.5ml syringe format, valued at $3,918.45 under a firm fixed-price contract type. The award was made on August 22, 2025, with an ultimate completion date of August 25, 2025. This delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a $1,064.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Boostrix TDAP vaccine syringes (0.5ML) on August 11, 2025, with completion targeted for August 12, 2025. This non-set-aside delivery order represents a small-value transaction under AmerisourceBergen's broader pharmaceutical supply arrangement with DLA. The product will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Boostrix TDAP vaccine in 0.5mL syringes, with a ceiling value of $13,188.24. This competitively awarded, firm fixed-price delivery order is scheduled for completion by November 4, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract contains no set-aside designation, indicating open competition among...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Boostrix TDAP vaccine in syringe form (0.5mL) with a ceiling value of $1,064.40. This competitively awarded, firm fixed-price delivery order was issued on July 23, 2025, with an ultimate completion date of July 24, 2025. The contract utilizes no set-aside designation and will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is executed under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Boostrix TDAP vaccine in 0.5ml syringes, with a contract value of $1,890.22. This non-set-aside delivery order, awarded on August 11, 2025, represents a firm fixed-price transaction with an ultimate completion date of August 12, 2025. The vaccine will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, serving the company's role as a critical pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of Boostrix TDAP vaccine syringes (0.5mL) with a ceiling value of $13,571.10. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is expected to be completed by May 13, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. This delivery order represents a task under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Boostrix TDAP vaccine in 0.5mL syringes, with a contract ceiling value of $3,691.24. The award was executed on July 22, 2025, with an ultimate completion date of July 23, 2025, utilizing firm fixed-price pricing on a competitive, non-set-aside basis. Performance will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Boostrix TDAP vaccine in 0.5mL syringe format, valued at $5,119.60. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is scheduled for completion by November 10, 2025, and will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...